# Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 26% Upside Potential with Strong Buy Ratings

- Link: https://www.directorstalkinterviews.com/merit-medical-systems-inc-mmsi-stock-analysis-a-26-upside-potential-with-strong-buy-ratings/4121241180
- Published: 2026-02-23T11:27:16+00:00
- Author: Madison Wilson

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare
sector specializing in medical instruments and supplies, is capturing investor attention
with a significant upside potential and robust buy ratings. Based in South Jordan,
Utah, the company is strategically positioned at the intersection of innovation 
and demand, offering a diverse range of medical products for interventional, diagnostic,
and therapeutic procedures. Its market cap stands at a notable $4.87 billion, reflecting
its established presence in the medical technology landscape.

**Financial Performance and Valuation Metrics**

Currently trading at $82.21, Merit Medical Systems’ stock shows a stable price change
with a 52-week range between $78.86 and $107.04. The forward P/E ratio is calculated
at 20.34, suggesting a reasonable valuation relative to its earnings outlook. The
absence of a trailing P/E ratio or PEG ratio indicates that the company is either
reinvesting profits into growth or still finding its footing in terms of profitability
metrics.

The company’s revenue growth of 13.00% highlights its capability to expand its market
reach and enhance its product offerings. With an EPS of 1.95 and a return on equity
of 8.30%, Merit Medical is demonstrating solid financial management and shareholder
value creation. The free cash flow of approximately $199.78 million provides a strong
financial foundation for further investment and innovation.

**Analyst Ratings and Target Price**

Merit Medical Systems enjoys positive sentiment from analysts, with 10 buy ratings
and only a single hold rating. No sell ratings indicate strong confidence in the
company’s performance and strategic direction. The target price range is set between
$90.00 and $122.00, with an average target of $103.64. This suggests a potential
upside of 26.06%, an attractive proposition for investors seeking growth opportunities
in the healthcare sector.

**Technical Indicators**

From a technical perspective, MMSI’s 50-day moving average is $84.32, while its 
200-day moving average is slightly higher at $87.25. The RSI (14) stands at 40.75,
indicating that the stock is neither overbought nor oversold. However, the MACD 
of -0.58 and signal line of -0.95 could suggest a bearish momentum in the short 
term, warranting cautious optimism from technical traders.

**Product Portfolio and Market Reach**

Merit Medical Systems operates through two primary segments: Cardiovascular and 
Endoscopy. The company’s offerings include a comprehensive range of products such
as micropuncture kits, guide wires, angiographic needles, and embolotherapy products.
It also provides custom procedural solutions and sensor components for microelectromechanical
systems, catering to a wide array of medical needs.

The company’s products are distributed through direct sales, distributors, and OEM
partners, ensuring a broad market reach and the ability to penetrate various healthcare
settings. This extensive distribution network supports Merit Medical’s growth and
revenue generation capabilities.

**Investment Considerations**

For investors, Merit Medical Systems presents a compelling opportunity in the healthcare
sector. The company’s innovative product line, robust revenue growth, and strong
analyst support underscore its potential for continued success. While some valuation
metrics are not available, the forward-looking indicators and analyst ratings provide
a positive outlook.

Investors considering MMSI should weigh these factors alongside broader market conditions
and their individual risk tolerance. With a significant 26% upside potential, Merit
Medical Systems is well-positioned to capitalize on growth opportunities in the 
dynamic healthcare market, making it an intriguing candidate for investment portfolios
focused on long-term value creation.

Share on: